Read More Pharma Industry News ALTA-1L trial results : Takeda’s ALUNBRIG continues to show superiority over crizotinib ALTA-1L trial results : Takeda Pharmaceutical says that ALUNBRIG (brigatinib), its tyrosine kinase inhibitor (TKI), is continuing to… bypharmanewsdailyNovember 23, 2019
